| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 66 |
| 1 | RISANKIZUMAB-RZAA | 55 |
| 2 | INFLIXIMAB | 35 |
| 3 | VEDOLIZUMAB | 32 |
| 4 | AZATHIOPRINE | 29 |
| 5 | USTEKINUMAB | 28 |
| 6 | PREDNISONE | 27 |
| 7 | INFLIXIMAB-DYYB | 26 |
| 8 | UPADACITINIB | 24 |
| 9 | CIPROFLOXACIN HYDROCHLORIDE | 22 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | INFLIXIMAB-DYYB | 26 | 0.0075 |
| 1 | PENICILLIN G | 16 | 0.0068 |
| 2 | ADALIMUMAB-ADBM | 1 | 0.0037 |
| 3 | ODEVIXIBAT | 1 | 0.0025 |
| 4 | CEFUROXIME SODIUM | 3 | 0.0024 |
| 5 | TRISODIUM CITRATE DIHYDRATE | 14 | 0.0020 |
| 6 | NEOMYCIN OINTMENT | 4 | 0.0016 |
| 7 | CLEMASTINE FUMARATE | 2 | 0.0014 |
| 8 | CEFUROXIME | 14 | 0.0012 |
| 9 | AZATHIOPRINE SODIUM | 3 | 0.0012 |
| # | Drug class | Count |
|---|---|---|
| 0 | Interleukin-23 Antagonist [EPC] | 85 |
| 1 | Tumor Necrosis Factor Blocker [EPC] | 66 |
| 2 | Corticosteroid [EPC] | 38 |
| 3 | Integrin Receptor Antagonist [EPC] | 32 |
| 4 | Purine Antimetabolite [EPC] | 29 |
| 5 | Interleukin-12 Antagonist [EPC] | 28 |
| 6 | Janus Kinase Inhibitor [EPC] | 24 |
| 7 | Aminosalicylate [EPC] | 22 |
| 8 | Fluoroquinolone Antibacterial [EPC] | 20 |
| 9 | Folate Analog Metabolic Inhibitor [EPC] | 19 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Ileal Bile Acid Transporter Inhibitor [EPC] | 1 | 0.0022 |
| 1 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 2 | Recombinant Human Deoxyribonuclease 1 [EPC] | 16 | 0.0008 |
| 3 | Interleukin-23 Antagonist [EPC] | 85 | 0.0008 |
| 4 | GLP-2 Analog [EPC] | 8 | 0.0006 |
| 5 | Penem Antibacterial [EPC] | 17 | 0.0005 |
| 6 | Provitamin D2 Compound [EPC] | 14 | 0.0005 |
| 7 | Integrin Receptor Antagonist [EPC] | 32 | 0.0004 |
| 8 | General Anesthetic [EPC] | 16 | 0.0004 |
| 9 | Purine Antimetabolite [EPC] | 29 | 0.0003 |